| __timestamp | Arrowhead Pharmaceuticals, Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 1513000 |
| Thursday, January 1, 2015 | 57410147 | 12573000 |
| Friday, January 1, 2016 | 41454452 | 42238000 |
| Sunday, January 1, 2017 | 31690298 | 69800000 |
| Monday, January 1, 2018 | 52968505 | 113773000 |
| Tuesday, January 1, 2019 | 81048686 | 179362000 |
| Wednesday, January 1, 2020 | 128874979 | 266946000 |
| Friday, January 1, 2021 | 206342000 | 438633000 |
| Saturday, January 1, 2022 | 297307000 | 461645000 |
| Sunday, January 1, 2023 | 353188000 | 387332000 |
| Monday, January 1, 2024 | 505870000 | 320653000 |
Data in motion
In the rapidly evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Arrowhead Pharmaceuticals, Inc. have been at the forefront of this trend, with their R&D expenses reflecting their dedication to pioneering advancements.
From 2014 to 2023, Arrowhead Pharmaceuticals saw a staggering increase in R&D spending, growing by over 1,400%, from approximately $23 million to $353 million. Meanwhile, CRISPR Therapeutics AG, known for its groundbreaking work in gene editing, increased its R&D expenses by an impressive 25,500%, reaching nearly $387 million in 2023 from a modest $1.5 million in 2014.
This data highlights the intense focus on innovation within the biotech sector, as these companies invest heavily in developing cutting-edge therapies that could revolutionize healthcare.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: United Therapeutics Corporation vs CRISPR Therapeutics AG
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Mesoblast Limited
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.